Revenue | ₹85.94Cr |
Net Profits | ₹0.14Cr |
Net Profit Margins | 0.16% |
Tatva Chintan Pharma Chem Ltd’s revenue jumped 0.61% since last year same period to ₹85.94Cr in the Q3 2024-2025. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 2.47% jump in its revenue since last 3-months.
Tatva Chintan Pharma Chem Ltd’s net profit fell -95.95% since last year same period to ₹0.14Cr in the Q3 2024-2025. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 121.21% jump in its net profits since last 3-months.
Tatva Chintan Pharma Chem Ltd’s net profit margin fell -95.98% since last year same period to 0.16% in the Q3 2024-2025. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 120.7% jump in its net profit margins since last 3-months.
The revenue for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was ₹85.94Cr.
The net profit for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was ₹0.14Cr.
The net profit margin for Tatva Chintan Pharma Chem Ltd in the Q3 results 2024 was 0.16%.
The revenue for Tatva Chintan Pharma Chem Ltd in the Q3 results 2023 was ₹85.42Cr.
The net profit for Tatva Chintan Pharma Chem Ltd in the Q3 results 2023 was ₹3.46Cr.
The net profit margin for Tatva Chintan Pharma Chem Ltd in the Q3 results 2023 was 4.05%.